Ucloudlink
- Country
- Ownership
- -
- Employees
- 393
- Market Cap
- -
- Introduction
uCloudlink Group, Inc. engages in the provision of data connectivity services. The firm is also involved in selling Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet. The company was founded by Chao Hui Chen and Zhi Ping Peng on August 25, 2014 and is headquartered in Hong Kong.
Yaqrit Secures £2.2 Million NIHR Grant for Pivotal DIALIVE Liver Support Device Trials
Yaqrit has received a £2.2 million ($2.85 million) grant from the UK's National Institute for Health and Care Research to fund pivotal trials of its DIALIVE liver support device across 13 UK centers.
UK Life Sciences Sector Faces Manufacturing Gap Despite Research Excellence
The UK maintains world-leading position in life sciences research and innovation, but faces significant challenges in translating scientific discoveries into domestic manufacturing capabilities.
UCL Repair with Internal Bracing Shows Faster Recovery Than Traditional Tommy John Surgery
A comprehensive study of 461 competitive athletes reveals UCL repair with internal bracing enables return to practice in 6.7 months compared to 10.2 months for traditional reconstruction.
SAFIR-ABC10 Trial: Precision Medicine Approach Aims to Extend Survival in Bile Duct Cancer
The SAFIR-ABC10 trial is a precision medicine study offering tailored therapies based on the genetic profile of bile duct tumors.
Brain Shrinkage in Alzheimer's Immunotherapy Linked to Amyloid Plaque Removal, Not Tissue Damage
A new study suggests brain volume loss in Alzheimer's immunotherapy is due to amyloid plaque removal, not neuronal damage.
Accelerated MRI Scans Show Promise in Alzheimer's Diagnosis and Monitoring
A new MRI technology, Wave-CAIPI, triples the speed of diagnostic scans without compromising image quality, potentially easing bottlenecks in Alzheimer's care.
CAR T-Cell Therapy Trial Offers Hope for Severe Lupus Patients in the UK
A Phase 1 clinical trial is underway in the UK to assess CAR T-cell therapy for severe lupus, offering a potential alternative to lifelong medication.
Lecanemab's Mortality Risk: UCL Professor Raises Concerns Over Alzheimer's Drug
Lecanemab, an Alzheimer's drug initially hailed as a breakthrough, faces scrutiny due to potential increased mortality risks, according to a UCL professor's analysis.